Skip to content

Author

Masamichi Ito

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A DNA damage checkpoint drives phenotypic transition in cardiomyopathy

Hypertrophic cardiomyopathy (HCM) arises from sarcomeric gene mutations, yet the mechanisms determining whether hypertrophic remodelling remains compensated or progresses to heart failure remain unresolved. Although energetic demand and oxidative stress are increased in HCM, whether these changes reflect metaboli...

J. Komuro, T. Jimba, T. Ko et al. · 0 citations
Nov 2026

Abstract 6498: CRISPRi Screening Identifies PIAS4 as a Regulator of NRF2-Associated Stress Adaptation in Heart Failure Failure

Background: Activation of the DNA damage response (DDR) contributes to cardiac dysfunction through the p53/p21 pathway, yet the molecular mechanisms governing DDR adaptation in terminally differentiated cardiomyocytes remain incompletely understood. We aimed to identify key regulators of cardiac DDR and stress adapt...

Masayuki Kubota, M. Ito, Manami Katoh et al. · 0 citations
Open access Sep 2026

REN-former prioritizes candidate regulators of kidney disease-state transitions through single-cell foundation modeling and human genetics

Background Acute kidney injury (AKI)-to-chronic kidney disease (CKD) transition is associated with dynamic changes in tubular cell state. However, conventional single-cell transcriptomic analyses primarily identify genes differentially expressed between disease states and do not directly evaluate genes associated with...

I. Mimura, Sosuke Hosokawa, Y. Hirakawa et al. · 0 citations
Open access Sep 2026

Vitamin D Pathway Activation Reduces Cardiomyocyte DNA Damage and Improves Cardiac Contractility in Preclinical Models.

BACKGROUND In heart failure (HF), DNA damage caused by various external stressors contributes to cardiac dysfunction through the activation of DNA damage response pathways. To date, no clinical strategies have been established to restore cardiac function by reducing accumulated DNA damage. We previously found that vita...

Masamichi Ito, Manami Katoh, Masayuki Kubota et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.